UK Tackles Rising Tide of Untreatable Infections

Antibiotic resistance poses a significant health threat in the UK, with approximately 400 new cases of resistant infections emerging weekly in 2024. Bacteraemia, a potentially fatal bloodstream infection, has seen a 9.3% increase since 2023, reaching 20,484 cases. This rise exacerbates the risk of severe illness and death for affected individuals, particularly those in the most deprived communities who face a 47.2% higher rate of resistant bacteraemia.

The UK is two years into a five-year National Action Plan (2024-2029) aimed at curbing this escalating crisis. While NHS primary care antibiotic use has slightly decreased between 2019 and 2024, private dispensing has nearly doubled, contributing to an overall increase in primary care antibiotic use. Adults over 45, especially those above 74, are most vulnerable.

Efforts are underway to address the problem through better infection prevention, responsible antibiotic use, and rapid testing. Global collaboration is also key, with the UK working with international partners to research new treatments, including microbiome therapies and bacteriophage treatments, and to develop innovative funding models for new antibiotics. Regulatory bodies are supporting the safe and timely introduction of these advancements.